Optigenex Inc. Cautions Consumers to Be Aware of a Product Called "FUSION Powered by ac-11(R)", a Weight Loss Formula that Does Not Comply with Published Data on ac-11(R) Efficacy and Is Not Authorized by Optigenex, the Owner of ac-11(R)
ACCESSWIRE - Mon Dec 22, 11:45AM CST
Optigenex Reports that the Company is Taking Legal Measures Stop Further Manufacturing of FUSION, Along With Several Other Unauthorized ac-11(R) Products
Optigenex Inc. Reports New Research Milestone for Onnit Lab's Proprietary Supplement, Alpha BRAIN(TM) with ac-11(R)
ACCESSWIRE - Wed Dec 17, 7:35AM CST
The Boston Memory Center, the Nation's Leading Independent Clinical Evaluator of Memory Loss and Related Cognitive Disorders, Announces Successful Results of its Just Released Double Blind, Randomized, Placebo-Based Human Trial
Optigenex and Hill Pharma Enter Into Agreement to Develop Innovative Sports Nutrition and Weight Management Products
ACCESSWIRE - Tue Oct 07, 8:15AM CDT
Companies Plan to Unveil Initial Product Offerings at Supply Side West in Las Vegas, Nevada on October 8, 2014